High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.

by Miguel Ángel López Zúñiga, Aida Moreno-Moral, Ana Ocaña-Granados, Francisco Andrés Padilla-Moreno, Alba María Castillo-Fernández, Dionisio Guillamón-Fernández, Carolina Ramírez-Sánchez, María Sanchez-Palop, Justo Martínez-Colmenero, María Amparo Pimentel-Villar, Sara Blázquez-Roselló, José Juan Moreno-Sánchez, María López-Vílchez, Inmaculada Prior-Sánchez, Rosario Jódar-Moreno, Miguel Ángel López Ruz
Published 2021-01-01